The international standard for granulocyte-macrophage colony stimulating factor (GM-CSF). Evaluation in an international collaborative study. Participants of the Collaborative Study.

No abstract is available for this paper.

• Publication year

  1995

• Venue

  JIM - Journal of Immunological Methods

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/0022-1759(94)00273-yPMID 7868919
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Granulocyte-macrophage colony-stimulating factor (GM-CSF): A variety of possible applications in clinical medicine

  2005cited by this paper
• The colony stimulating factors discovery, development, and clinical applications

  1990cited by this paper
• The biology of human granulocyte-macrophage colony-stimulating factor (GM-CSF).

  1990cited by this paper
• Effect of recombinant human granulocyte-macrophage colony-stimulating factor on hematopoietic reconstitution after high-dose chemotherapy and autologous bone marrow transplantation.

  1988cited by this paper
• SCAN, an exploratory program for preliminary analysis of bioassay and immunoassay data.

  1985cited by this paper
• Human GM-CSF: molecular cloning of the complementary DNA and purification of the natural and recombinant proteins.

  1985cited by this paper
• Iterative weighted regression analysis of logit responses: a computer program for analysis of bioassays and immunoassays.

  1982cited by this paper

• Pichia pastoris versus Saccharomyces cerevisiae: a case study on the recombinant production of human granulocyte-macrophage colony-stimulating factor

  2017cites this paper
• SERS-based Immunoassay in a Microfluidic System for the Multiplexed Recognition of Interleukins from Blood Plasma: Towards Picogram Detection

  2017cites this paper
• Differential sensitivity of lipegfilgrastim and pegfilgrastim to neutrophil elastase correlates with differences in clinical pharmacokinetic profile

  2016cites this paper
• Preparation and characterization of monopegylated human granulocyte-macrophage colony-stimulating factor.

  2008cites this paper
• Production of Nonclassical Inclusion Bodies from Which Correctly Folded Protein Can Be Extracted

  2008cites this paper
• Choice of the adequate quantification method for recombinant human GM-CSF produced in different host systems

  2002cites this paper
• Total cytokine immunoassay: a more accurate method of cytokine measurement?

  2001cites this paper
• PURIFICATION AND CHARACTERIZATION OF THE CLONED HUMAN GM-CSF GENE EXPRESSED IN ESCHERICHIA COLI

  1999cites this paper
• Variables That Affect Assays for Plasma Cytokines and Soluble Activation Markers

  1999cites this paper
• Levels of Cytokines and Immune Activation Markers in Plasma in Human Immunodeficiency Virus Infection: Quality Control Procedures

  1998cites this paper
• Developments in immunological standardization.

  1998cites this paper
• Biological assays: their role in the development and quality control of recombinant biological medicinal products.

  1996cites this paper
• Development and shelf-life determination of recombinant human granulocyte--macrophage colony-stimulating factor (LEUKINE, GM-CSF).

  1996cites this paper
• Quantitative cell line based bioassays for human cytokines.

  1995cites this paper
• Immunoassays for detecting cytokines: what are they really measuring?

  1995cites this paper